Finding the best aspirin dose to prevent Lynch syndrome cancers
Treatments studied
Part of Cancer, Digestive system, Genetic & congenital clinical trials.
This trial is testing different doses of aspirin to see which one works best to prevent cancer in people with Lynch syndrome. If you have Lynch syndrome, taking aspirin daily might lower your risk, and this study will help find the safest and most effective dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of Lynch syndrome (a genetic condition that raises cancer risk).
- You must be able to swallow tablets.
- You must not be taking other pain relievers (like ibuprofen) more than 3 times a week, or be willing to switch to the study aspirin.
- You must not have any bleeding disorders, stomach ulcers, or need to be on blood thinners like warfarin.
- You must not be allergic to aspirin or have aspirin-sensitive asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system interacts with the gut lining in people with Lynch syndrome and those without. It may help us better understand how Lynch syndrome affects the body.
This trial tests whether daily aspirin or naproxen can “intercept” (stop) cancer from starting or coming back in people with Lynch syndrome who are currently cancer-free. Participants are randomly assigned to one of the two drugs, and neither the participant nor the team knows which one you’re taking.
This trial tests whether mesalamine, a medicine used for bowel inflammation, can help prevent colorectal cancer in people with Lynch syndrome who do not currently have cancer. It may help by lowering the chance that new pre-cancer growths form over time.
This study is testing whether a simple blood test can safely replace some of the more invasive procedures used to monitor people with Lynch syndrome, a condition that increases the risk of certain cancers (especially colorectal and uterine). If the blood test works as well, it could mean fewer colonoscopies and other invasive tests for those with Lynch syndrome.
This study tests a special CAD-EYE system to help detect abnormal (potentially cancer-related) growths during colonoscopy in people with Lynch syndrome. It may improve how reliably clinicians find lesions early, when treatment can be easier.
This study checks tumor samples from people having surgery for colorectal cancer to look for a genetic condition called Lynch syndrome, which can increase the risk of other cancers. Finding it early can help you and your family take steps to protect your health.
Hear when a new Lynch Syndrome I (Site-specific Colonic Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.